
Sandoz Inc. is a global leader in generic and biosimilar pharmaceuticals, pioneering affordable access to high-quality medicines for patients worldwide.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Sandoz Inc. has recently focused on expanding its biosimilar portfolio, enhancing digital supply chain capabilities, and increasing global market penetration in response to rising demand for affordable medicines.
Launch of new biosimilar products targeting high-demand therapeutic areas
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Sandoz Inc. develops, manufactures, and markets a broad portfolio of generic and biosimilar medicines, focusing on making high-quality treatments more accessible and affordable. The company’s operations span research, development, and large-scale distribution, supporting healthcare systems worldwide. Sandoz is known for its innovation in biosimilars and its robust pipeline of products addressing a wide range of therapeutic areas. As a global leader, Sandoz partners with healthcare professionals and organizations to improve patient outcomes and drive sustainable healthcare solutions.
Basel, Switzerland
1886
SDZ